# Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With External Genital Warts

> **NCT02849262** · PHASE2 · COMPLETED · sponsor: **Maruho Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Condylomata Acuminata (External)

## Interventions

- **DRUG:** Omiganan (CLS001) topical gel
- **DRUG:** Vehicle topical gel

## Key facts

- **NCT ID:** NCT02849262
- **Lead sponsor:** Maruho Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2017-03-21
- **Final completion:** 2017-03-21
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02849262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02849262, "Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With External Genital Warts". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02849262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*